Arcus Biosciences Inc. logo

Arcus Biosciences Inc.

RCUS | NYSE
Chart Builder DCF Calculator
$25.95
+$0.71 (+2.81%)
At close: Sep 21, 2026, 4:00 PM ET
$25.95
$0 (0.00%)
After-hours: Sep 21, 2026, 4:06 PM ET

Market Data

Market Cap
$3.17B
Enterprise Value
$2.68B
Beta
0.81
Average Volume
1.2M
Shares Outstanding (Diluted)
126.1M
Shares Change YoY
18.4%
Institutional Ownership
94.98%
Exchange
NYSE
ISIN
US03969F1093

Price Performance

Price Change 1M
-15.0%
Price Change 3M
-7.9%
Price Change 6M
20.9%
Price Change YTD
11.4%
Price Change 1Y
107.3%
Price Change 3Y
31.6%
Price Change 5Y
-27.9%
1M CAGR (ann.)
-10.9%
1Y CAGR (ann.)
109.8%
5Y CAGR (ann.)
-4.9%
All-Time CAGR
4.8%

Valuation

PE Ratio
-6.60
Forward PE
N/A
PEG Ratio
0.31
Forward PEG
2.41
PS Ratio
27.90
Forward PS
69.80
PB Ratio
7.03
P/FCF Ratio
-5.32
P/Adj. FCF Ratio
-4.70
P/OCF Ratio
-6.90
EV/Sales
22.87
EV/EBIT
-6.24
EV/EBITDA
-6.39
EV/FCF
-4.37
Earnings Yield
-15.1%
FCF Yield
-18.8%
Adj. FCF Yield
-21.3%

Financial Health

Net Cash
$601M
Total Debt
$114M
Cash & Short-Term Investments
$702M
Total Assets
$924M
Current Ratio
3.82
Quick Ratio
3.82
Debt / Equity Ratio
0.25
Debt / EBITDA
-0.27
Debt / FCF
-0.19
OCF / Debt
-5.37
Interest Coverage
-21.13
Altman Z-Score
0.88
Piotroski F-Score
0

Margins & Profitability

Gross Profit Margin
94.0%
Operating Profit Margin
-415.4%
EBITDA Margin
-358.1%
Net Profit Margin
-386.3%
FCF Margin
-523.9%
Adj. FCF Margin
-594.0%
SBC / Revenue
53.9%
SBC Impact (per share)
-13.4%

Returns

Return on Assets
-48.9%
Return on Equity
-88.0%
Return on Invested Capital
-65.8%
Return on Capital Employed
-66.9%
Return on Tangible Assets
-48.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
-1.0%
Revenue CAGR 5Y
4.7%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
-12.2%
EPS CAGR 5Y
-32.3%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-42.5%
FCF CAGR 5Y
-98.4%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
18
EPS Growth Next 3Y
23.0%
Revenue Growth Next 3Y
52.5%
Earnings Date
Oct 26, 2026
EPS Estimate (next Q)
-$0.94
EPS Growth Est (next Q)
-26.0%
Revenue Est (next Q)
$11.03M
Revenue Growth Est (next Q)
-57.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$40
Price Target Upside
54.1%

Cash Flow

Operating Cash Flow
$-612M
Free Cash Flow
$-613M
Adj. Free Cash Flow
$-695M
FCF Per Share
-$3.77
OCF Per Share
-$3.76
OCF/S Ratio
-405.1%

Income Statement

Revenue
$117M
Gross Profit
$110M
Operating Income
$-486M
EBITDA
$-419M
Net Income
$-452M
EPS (Diluted)
-$3.93
Revenue / Employee
$194.68K
Profit / Employee
$-752.08K
Employees
601

© 2026 bestshares.com. All rights reserved.